Your browser doesn't support javascript.
loading
Drug-drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation.
Sychev, Dmitry; Mirzaev, Karin; Cherniaeva, Marina; Kulikova, Maria; Bochkov, Pavel; Shevchenko, Roman; Gorbatenkova, Svetlana; Golovina, Olga; Ostroumova, Olga; Bahteeva, Damirya; Rytkin, Eric.
Affiliation
  • Sychev D; Department of Clinical Pharmacology and Therapy of Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
  • Mirzaev K; Department of Personalized Medicine, Research Institute of Molecular and Personalized Medicine of Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation,
  • Cherniaeva M; Department of Internal and Preventive Medicine of Federal State Budgetary Institution of Higher Professional Education "Central State Medical Academy of the Presidential Administration of the Russian Federation", Marshal Timoshenko street,19, building 1A, 121359, Moscow, Russia.
  • Kulikova M; State Budgetary Institution of Health "Hospital for War Veterans No. 2" of the Department of Health of Moscow, Volgogradsky prospect, Moscow, Russia.
  • Bochkov P; Department of Clinical Pharmacology and Therapy of Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
  • Shevchenko R; Department of Personalized Medicine, Research Institute of Molecular and Personalized Medicine of Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation,
  • Gorbatenkova S; Department of Personalized Medicine, Research Institute of Molecular and Personalized Medicine of Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation,
  • Golovina O; State Budgetary Institution of Health "Hospital for War Veterans No. 2" of the Department of Health of Moscow, Volgogradsky prospect, Moscow, Russia.
  • Ostroumova O; Department of Clinical Pharmacology and Therapy of Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
  • Bahteeva D; Department of Therapy and Polymorbid Pathology of Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
  • Rytkin E; Department of Clinical Pharmacology and Therapy of Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
Drug Metab Pers Ther ; 35(3)2020 09 04.
Article in En | MEDLINE | ID: mdl-32975202
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Calcium Channel Blockers / Verapamil / Amlodipine / Rivaroxaban Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Aged80 / Female / Humans / Male Language: En Journal: Drug Metab Pers Ther Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Calcium Channel Blockers / Verapamil / Amlodipine / Rivaroxaban Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Aged80 / Female / Humans / Male Language: En Journal: Drug Metab Pers Ther Year: 2020 Document type: Article Affiliation country: Country of publication: